Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06614309 · ClinicalTrials.gov registry record · NA

Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog

A NA study of Long COVID, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT06614309 is a NA study of Long COVID that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 45 participants, below the 2,187-participant average among 50 other Long COVID trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06614309, a NA study of Long COVID, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

This study aims to assess the effects of both acute and chronic exposures to hypoxia and hypercapnia in patients with Long COVID syndrome.

Conditions Studied

Long COVID

Interventions

  • OTHER Acute Intermittent Hypoxia
  • OTHER Acute Placebo Visit
  • OTHER Acute Progressive Carbon Dioxide
  • OTHER Training: Progressive Carbon Dioxide Ramping
  • OTHER Training: Intermittent Hypoxic Exposure

Study Locations (1)

Arizona

  • Mayo Clinic in Arizona - Scottsdale

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2024-09-24
Est. Completion 2026-05
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06614309

The ClinicalTrials.gov registry entry for NCT06614309 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,187-participant average among 50 other Long COVID trials with a reported enrollment target (98% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Long COVID appearing as the primary indexed condition, and to 5 interventions - of which Acute Intermittent Hypoxia is the first listed.

NCT06614309 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT06614309 about?

NCT06614309 is a clinical study titled "Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog". This study aims to assess the effects of both acute and chronic exposures to hypoxia and hypercapnia in patients with Long COVID syndrome.

What is the current status of trial NCT06614309?

This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2024-09-24. Estimated completion is 2026-05.

What conditions does trial NCT06614309 study?

This clinical trial studies the following conditions: Long COVID.

What interventions are being tested in trial NCT06614309?

The interventions under investigation include: Acute Intermittent Hypoxia (OTHER), Acute Placebo Visit (OTHER), Acute Progressive Carbon Dioxide (OTHER), Training: Progressive Carbon Dioxide Ramping (OTHER), Training: Intermittent Hypoxic Exposure (OTHER).

Who is sponsoring clinical trial NCT06614309?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06614309 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Long COVID

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Long COVID

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.